LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
| Total assets (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $142.3B | +41.0% | 19.3% | 12.2% |
| Total assets (Q2 2026) | $142.3B |
|---|---|
| YoY | +41.0% |
| 5-year CAGR | 19.3% |
| 10-year CAGR | 12.2% |
Total assets
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $112.5B | +42.9% |
| 2024 | $78.7B | +23.0% |
| 2023 | $64.0B | +29.3% |
| 2022 | $49.5B | +1.4% |
| 2021 | $48.8B | +4.7% |
| 2020 | $46.6B | +18.7% |
| 2019 | $39.3B | −10.5% |
| 2018 | $43.9B | −2.4% |
| 2017 | $45.0B | +15.9% |
| 2016 | $38.8B | +9.1% |
| 2015 | $35.6B | −2.0% |
| 2014 | $36.3B | +3.0% |
| 2013 | $35.2B | +2.5% |
| 2012 | $34.4B | +2.2% |
| 2011 | $33.7B | +8.6% |
| 2010 | $31.0B | +12.9% |
| 2009 | $27.5B | −6.0% |
| 2008 | $29.2B | — |